Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - thieme-connect.com
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

[引用][C] Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J DOUXFILS, A TAMIGNIAU… - Thrombosis and …, 2013 - pascal-francis.inist.fr
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the
therapeutic monitoring of patients treated with rivaroxaban CNRS Inist Pascal-Francis CNRS …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - researchportal.unamur.be
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

[PDF][PDF] Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - researchgate.net
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - europepmc.org
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - thieme-connect.com
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - pubmed.ncbi.nlm.nih.gov
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

A Tamigniau, B Chatelain, C Chatelain… - Thrombosis and …, 2013 - cir.nii.ac.jp
抄録< jats: title> Summary</jats: title>< jats: p> Possibilities to monitor rivaroxaban therapy
could be useful in certain circumstances. Prothrombin time (PT) or chromogenic anti-Xa …

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.

J Douxfils, A Tamigniau, B Chatelain… - … journal for vascular …, 2013 - dial.uclouvain.be
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …

[PDF][PDF] Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

J Douxfils, A Tamigniau, B Chatelain… - Thrombosis and …, 2013 - pure.unamur.be
Possibilities to monitor rivaroxaban therapy could be useful in certain circumstances.
Prothrombin time (PT) or chromogenic anti-Xa assays such as the Biophen Direct Factor Xa …